Sepul Bio begins clinical trial of ultevursen for USH2A-associated RP
Sepul Bio begins clinical trial of ultevursen for USH2A-associated RP
Search
Search results
Giving in memory
Celebrate the life of your loved one, by donating in their memory and help us fund more research and support, now.
About us
Retina UK is a charity supporting people affected by inherited sight loss and investing in medical research to help make their challenges a thing of the past.
Volunteering FAQs
These are some of the most commonly asked questions about volunteering for our charity.
Nanoscope Announces topline results from randomised phase 2B trial of MCO-010 for retinitis pigmentosa
Nanoscope Therapeutics has announced positive results from their two year randomised controlled phase 2b optogenetic therapy trial for late-stage retinitis pigmentosa (RP).
Great North Run 2024
The Great North Run is the largest half marathon in the world, taking place annually in North East England.
ProQR announces agreement with Laboratoires Théa for inherited retinal disease programmes
Biotechnology company ProQR has announced that two of its RNA therapy development programmes for inherited sight loss are being acquired by Laboratoires Théa, a company specialising in eye care products.
e-Newsletter January 2025
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Meet our community: Mark Baxter
My name is Mark Baxter and from an early age I was diagnosed with a deteriorating retinal eye condition called retinitis pigmentosa or RP for short, which will slowly lead to blindness.
Virtual TCS London Marathon
Back for 2023, the virtual TCS London Marathon lets you join our team close to home and get your marathon medal!